TY  - JOUR
AU  - Ricciuti, Biagio
PY  - 2019
TI  - Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
JF  - Journal of Thoracic Disease; Vol 11, Supplement 3 (March 12, 2019): Journal of Thoracic Disease
Y2  - 2019
KW  - 
N2  - In the last 20 years the clinical management of patients with advanced non-small cell lung cancer (NSCLC) has shifted form a histology-driven to a molecularly-based approach due to the identification of actionable genetic alterations and the subsequent development of highly efficacious targeted therapies.
UR  - https://jtd.amegroups.org/article/view/26881